Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin for cervical dystonia and blepharospasm in patients non-responsive to Botox
2010-018345-64Phase 4Completed
- Sponsor
- Policlinico Gemelli
- Start
- Jul 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of botulinum toxin type A in cervical dystonia (CD) and idiopathic blepharospasm (BEB), sponsored by Policlinico Gemelli. Primary endpoint: Efficacy of Xeomin in cervical dystonia and blepharospasm. Started Jul 2010; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
cervical dystonia (CD)idiopathic blepharospasm (BEB)
Beyond the preview
Go deeper on 2010-018345-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018345-64.